MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) plans to release its first-quarter 2026 financial and operating results before market open on Tuesday, May 5, 2026, and will host a conference call at 8:30 a.m. Eastern Time the same day.
The webcast will be available in listen-only mode at https://edge.media-server.com/mmc/p/3pztkve5.
Participants may register to join the call by telephone through the company’s registration link.
Neuronetics develops and markets medical technology for neurohealth disorders, including the NeuroStar Advanced Therapy system.
The company also operates Greenbrook TMS Inc. treatment centers in the United States, which provide transcranial magnetic stimulation therapy and other treatments for depression and related conditions.
The NeuroStar system has received clearance from the U.S. Food and Drug Administration for use in adults with major depressive disorder, as well as for certain patients with obsessive-compulsive disorder and adolescent patients ages 15 to 21.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.